Federal Register / Vol. 61, No. 107 / Monday, June 3, 1996 / Notices 27905

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Notice is hereby given of the meeting

of the National Cancer Institute Board of

Scientific Advisors Prevention Program

Working Group, June 13, 1996 at The

DoubleTree Hotel, 1750 Rockville Pike,

Rockville, Maryland.

This meeting will be open to the

public on June 13, from 8:30 a.m. to 9:30

a.m. for overview and discussion of the

Institute’s Prevention Program.

The meeting will be closed to the

public on June 13, from 9:30 a.m. to

adjournment for discussion of

confidential issues relating to the

review, discussion and evaluation of

individual programs and projects

conducted by the Clinical Trials

Extramural Program. These discussions

will reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

including consideration of personnel

qualifications and performance, the

competence of individual investigators

and similar matters, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Information pertaining to the meeting

may be obtained from Dr. Jack Gruber,

Executive Secretary, National Cancer

Institute Prevention Program Working

Group, National Cancer Institute, 6130

Executive Blvd., EPN, Rm 540,

Bethesda, MD 20892, (301–496–9740).

Individuals who plan to attend and

need special assistance such as sign

language interpretation or other

reasonable accommodations should

contact Dr. Jack Gruber in advance of

the meeting.

Dated: May 23, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13735 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Center for Research Resources

Special Emphasis Panel (SEP) meeting:

Name of SEP: Biomedical Research

Technology.

Date: June 28, 1996.

Time: 8:00 a.m.

Place: Doubletree Hotel, Halpin Room,

1750 Rockville Pike, Rockville, Maryland

20892, (301) 468–1100.

Contact Person: Dr. Charles G.

Hollingsworth, Scientific Review

Administrator, 6705 Rockledge Drive, MSC

7965, Room 6018, Bethesda, MD 20892–7965,

(303) 435–0818.

Purpose/Agenda: To evaluate and review

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.371, Biomedical Research

Technology, National Institutes of Health,

HHS)

Dated: May 28, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13737 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Center for Research

Resources; Amended Notice of

Meeting

Notice is hereby given of a change in

the meeting of the Scientific and

Technical Review Board on Biomedical

and Behavioral Research Facilities, on

June 18–19, 1996, Holiday Inn, Georgia

Room, 8120 Wisconsin Avenue,

Bethesda, MD 20814, which was

published in the Federal Register on

May 7, 1996, 61 FR 20533.

The committee was to have convened

June 18–19, 1996, but will now meet

June 18–20, 1996.

The meeting will be open to the

public on June 18, from 8:00 a.m. to 8:30

a.m. The meeting will be closed on June

18, from 8:30 a.m. until adjournment on

June 20.

Dated: May 29, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13816 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Eye Institute; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Eye Institute Special Emphasis

Panel (SEP) meeting:

Name of SEP: Clinical Research.

Date: June 17, 1996.

Time: 8:30 a.m.

Place: Holiday Inn Gaithersburg.

Contact Person: Andrew P. Mariani, Ph.D.,

Executive Plaza South, Room 350, 6120

Executive Blvd., Bethesda, MD 20892–7164,

(301) 496–5561.

Purpose/Agenda: Review of Grant

Applications.

The meeting will be closed in accordance

with provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. Applications

and/or proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.867, Vision Research:

National Institutes of Health)

Dated: May 28, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13740 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel (SEP) meetings:

Name of SEP: Diabetes and Endocrinology

Research Centers (DERCs).

Date: June 25–26, 1996.

Time: 8:30 a.m.—adjournment on June 26.

Place: Renaissance Mayflower Hotel, New

York Room, 1127 Connecticut Ave., N.W.,

Washington, D.C. 20036.

Contact Person: Roberta J. Haber, Ph.D.,

Natcher Building, Room 6AS–25N, National

Institutes of Health, Bethesda, Maryland

20892–6600, Phone: 301–594–8898.

Purpose/Agenda: To review and evaluate

research grant applications.

Name of SEP: Pathobiology of

Macrovascular Disease in Diabetes.

Date: July 1–3, 1996.

Time: 7:30 p.m.—adjournment on July 3.

Place: Silver Cloud Inn (room to be

announced), Seattle, Washington.

Contact Person: Francisco O. Calvo, Ph.D.,

Natcher Building, Room 6AS–37E, National

Institutes of Health, Bethesda, Maryland

20892–6600, Phone: 301–594–8897.

Purpose/Agenda: To review and evaluate

research grant application.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.
27906 Federal Register / Vol. 61, No. 107 / Monday, June 3, 1996 / Notices

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: May 28, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13736 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Aging; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings:

Name of Panel: National Institute on Aging

Special Emphasis Panel (Telephone

Conference Call).

Date of Meeting: June 12, 1996.

Time of Meeting: 1:00 p.m.—EDT.

Place of Meeting: Gateway Building, Room

2C212, 7201 Wisconsin Avenue, Bethesda,

Maryland 20892.

Purpose/Agenda: To review grant

applications.

Contact Person: Paul H. Lenz, Ph.D.,

Scientific Review Administrator, Gateway

Building, Room 2C212, National Institutes of

Health, Bethesda, Maryland 20892–9205,

(301) 496–9666.

This notice is being published less

than 15 days prior to the above meeting

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

Name of Panel: National Institute on Aging

Special Emphasis Panel (Telephone

Conference Call).

Date of Meeting: June 25, 1996.

Time of Meeting: 2:00 p.m.—EDT.

Place of Meeting: Gateway Building, Room

2C212, 7201 Wisconsin Avenue, Bethesda,

Maryland 20892.

Purpose/Agenda: To review a grant

application.

Contact Person: Paul H. Lenz, Ph.D.,

Scientific Review Administrator, Gateway

Building, Room 2C212, National Institutes of

Health, Bethesda, Maryland 20892–9205,

(301) 496–9666.

Name of Panel: National Institute on Aging

Special Emphasis Panel (Telephone

Conference Call).

Date of Meeting: July 9, 1996.

Time of Meeting: 1:00–2:00 p.m.—EDT.

Place of Meeting: Gateway Building, Room

2C212, 7201 Wisconsin Avenue, Bethesda,

Maryland 20892.

Purpose/Agenda: To review a grant

application.

Contact Person: Arthur D. Schaerdel, DVM,

Scientific Review Administrator, Gateway

Building, Room 2C212, National Institutes of

Health, Bethesda, Maryland 20892–9205,

(301) 496–9666.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.866, Aging Research,

National Institutes of Health)

Dated: May 28, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13739 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Vaccine Production Facility.

Date: June 11, 1996.

Time: 9:00 a.m.

Place: Bethesda Ramada, 8400 Wisconsin

Avenue, Bethesda, MD 20814, (301) 654–

1000.

Contact Person: Dr. Madelon C. Halula,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C16,

Bethesda, MD 20892, (301) 402–2636.

Purpose/Agenda: To evaluate contract

proposals.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less

than 15 days prior to the meeting due

to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: May 28, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13741 Filed 5–31–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute on

Drug Abuse Initial Review Group.

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: Molecular, Cellular

and Chemical Neurobiology Research

Subcommittee.

Date: June 3–5, 1996.

Time: 8:30 a.m.

Place: Key Bridge Marriott, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Rita Liu, Ph.D., Scientific

Review Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–22,

Telephone (301) 443–2620.

Name of Committee: Neuropharmacology

Research Subcommittee.

Date: June 3–5, 1996.

Time: 8:30 a.m.

Place: Key Bridge Marriott, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Syed Husain,, Ph.D,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Neurophysiology and

Neuroanatomy Research Subcommittee.

Date: June 3–5, 1996.

Time: 8:30 a.m.

Place: Key Bridge Marriott, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Human Development

Research Subcommittee.

Date: June 11–12, 1996.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: William C. Grace, Ph.D.

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: Epidemiology and

Prevention Research Subcommittee.

Date: June 11–13, 1996.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

The meetings will be closed in accordance

with provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. The

applications and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals